Active Pharmaceutical Ingredient (Generic)

REGORAFENIB

🩺 ANTINEOPLASTICS 💊 2 Marketed Brands
Clinical Profile:

*Metastatic colorectal cancer, Unresectable or metastatic gastrointestinal stromal tumours, Hepatocellular carcinoma (specialist use only):* Adult: 160 mg once daily for 21 consecutive days of repeated 28-day cycles, for dose adjustment consult product literature.

Marketed Brands Containing REGORAFENIB (2) Compare Brand Prices
Brand Name Manufacturer / Company Available Pack Sizes & Price Action
REGONIX 🏢 HIMMEL
Tab 40 mg 28: Rs.66000.00
View Details →
STIVARGA 🏢 BAYER
Tab 40 mg 28x3: Rs.360000.00
View Details →

Related Generics

Other generic formulations in the same therapeutic groups as REGORAFENIB.

PACLITAXEL 18 brand(s)
DOCETAXEL 12 brand(s)
OXALIPLATIN 12 brand(s)
METHOTREXATE 11 brand(s)
DOXORUBICIN 10 brand(s)
ETOPOSIDE 9 brand(s)
GEMCITABINE 9 brand(s)
IRINOTECAN HCl 9 brand(s)
CARBOPLATIN 7 brand(s)
CISPLATIN 7 brand(s)
RITUXIMAB 7 brand(s)
BEVACIZUMAB 6 brand(s)